Research Then & Treatments Now: NFCR-funded scientist Dr. Dvorak's discovery helped pave the way for researchers to develop treatments to halt tumor growth.
Molecular imaging combines conventional anatomic imaging with genomic testing and enables doctors to literally see cancer at its molecular or genetic level.
It’s important to understand cervical cancer - the disease known as a “silent killer” - and what women can do to improve our chances of beating it.
National Foundation for Cancer Research CEO Franklin Salisbury Jr. predicts: "It looks like 21st century medicine will be about cancer genomics."
In honor of 2017, we’ve put together seven cancer-fighting new year's resolutions. From screenings to sunscreen, these easy resolutions are worth keeping!
Dr. Web Cavenee and Dr. Paul B. Fisher discover a new pharmacological agent to treat glioblastoma multiforme (GBM), the deadliest brain cancer.
Ongoing fundraising efforts in honor of Lucy Stanovick seek to find a cure for metastatic cancer. To date, over $200,000 has been raised in Lucy’s name.
Sarah Byrd says she owes her life to Dr. Curt Civin, a pediatric oncologist specializing in leukemia research whose work is funded by NFCR.
Researchers from UNC, Chapel Hill found a subtype of bladder cancer has the same molecular signatures as a subset of breast cancer.
NFCR President and COO, Dr. Sujuan Ba, has spent this past year traveling the world to lead efforts and collaborate with top scientists. Read about some of the conferences, people and successes in 2016.
NBTS held its annual Gray Gala and pioneers in brain tumor research were honored, including Dr. Web Cavanee, Chairman of NFCR’s Scientific Advisory Board.
Dr. Daniel Von Hoff, Director of the NFCR Center for Targeted Cancer Therapies at TGen, has been selected as a 2016 Giants of Cancer Care® by OncLive.
On the Move with Dr. Ba
Cancer Research Science
Szent-Györgyi Prize Winners, Then and Now
5515 Security Lane, Suite 1105
Rockville, MD 20852
The National Foundation for Cancer Research (NFCR) is a 501(c)(3) tax-exempt nonprofit organization.
Tax ID #: 04-2531031
© Copyright 2020 National Foundation for Cancer Research. All Rights Reserved.